[go: up one dir, main page]

WO2000041670A3 - Formulations pharmaceutiques et procedes associes permettant une continuite de penetration - Google Patents

Formulations pharmaceutiques et procedes associes permettant une continuite de penetration Download PDF

Info

Publication number
WO2000041670A3
WO2000041670A3 PCT/TR2000/000001 TR0000001W WO0041670A3 WO 2000041670 A3 WO2000041670 A3 WO 2000041670A3 TR 0000001 W TR0000001 W TR 0000001W WO 0041670 A3 WO0041670 A3 WO 0041670A3
Authority
WO
WIPO (PCT)
Prior art keywords
soft
stick
methods
penetration
pharmaceutical forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2000/000001
Other languages
English (en)
Other versions
WO2000041670A2 (fr
Inventor
Ahmet Degirmenci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU38538/00A priority Critical patent/AU3853800A/en
Publication of WO2000041670A2 publication Critical patent/WO2000041670A2/fr
Anticipated expiration legal-status Critical
Publication of WO2000041670A3 publication Critical patent/WO2000041670A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Les médicaments appliqués de manière topique et présentant une certaine fluidité, tels que onguent ou pansement, sont retirés dans un délai assez court du fait de leur motilité excessive et des frottements subis sur leur site d'application, par exemple les lèvres, les articulations et autres zones corporelles. Ceci gène généralement la pénétration cutanée de la substance antivirale et ralentit le traitement topique. La présente invention se rapporte à des formulations et à des procédés qui assurent la continuité de pénétration et mettent en oeuvre pour faciliter le traitement des bâtonnets mous, des bâtonnets réparateurs mous, des crayons mous, des bâtonnets thermiques mous, des bâtonnets mous contenant de l'Acyclovir et des pansements de traitement de l'herpès de la lèvre.
PCT/TR2000/000001 1999-01-11 2000-01-11 Formulations pharmaceutiques et procedes associes permettant une continuite de penetration Ceased WO2000041670A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU38538/00A AU3853800A (en) 1999-01-11 2000-01-11 Pharmaceutical forms and methods for penetration continuity

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
TR99/00033 1999-01-11
TR9900033 1999-01-11
TR99/03291 1999-12-28
TR9903291 1999-12-28

Publications (2)

Publication Number Publication Date
WO2000041670A2 WO2000041670A2 (fr) 2000-07-20
WO2000041670A3 true WO2000041670A3 (fr) 2008-02-14

Family

ID=26666345

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2000/000001 Ceased WO2000041670A2 (fr) 1999-01-11 2000-01-11 Formulations pharmaceutiques et procedes associes permettant une continuite de penetration

Country Status (2)

Country Link
AU (1) AU3853800A (fr)
WO (1) WO2000041670A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005051259A2 (fr) 2003-11-28 2005-06-09 Coloplast A/S Produit de pansement
EP1784170B1 (fr) 2004-09-01 2008-01-09 LABTEC GESELLSCHAFT FüR TECHNOLOGISCHE FORSCHUNG UND ENTWICKLUNG MBH Patch a atrium
DE102005050654A1 (de) * 2005-10-20 2007-04-26 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Lippenpflaster

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4615633A (en) * 1983-11-09 1986-10-07 Societe Anonyme Dite: L'oreal Pharmaceutical or cosmetic composition in the form of a rod or stick constituted from two concentric fatty phases and a casting permitting its preservation and distribution
WO1998018472A1 (fr) * 1996-10-31 1998-05-07 Recordati S.A. Chemical And Pharmaceutical Company Compositions pharmaceutiques antiherpetiques contenant de l'acyclovir pour applicateurs locaux

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4615633A (en) * 1983-11-09 1986-10-07 Societe Anonyme Dite: L'oreal Pharmaceutical or cosmetic composition in the form of a rod or stick constituted from two concentric fatty phases and a casting permitting its preservation and distribution
WO1998018472A1 (fr) * 1996-10-31 1998-05-07 Recordati S.A. Chemical And Pharmaceutical Company Compositions pharmaceutiques antiherpetiques contenant de l'acyclovir pour applicateurs locaux

Also Published As

Publication number Publication date
AU3853800A (en) 2000-08-01
WO2000041670A2 (fr) 2000-07-20

Similar Documents

Publication Publication Date Title
PT84735B (pt) Aplicador de cosmeticos com uma ponta em forma de rolhao
AU589371B2 (en) Purine derivatives and use as therapeutic agent
PT2450043T (pt) Composição farmacêutica para uso dérmico no tratamento de psoríase compreendendo calcipotriol e betametasona
NO991910D0 (no) Antiherpes farmas°ytisk sammensetning inneholdende acyklovir for topiske applikatorer
IT8024370A0 (it) Composizione terapeutica di dimetil solfossido e procedimenti per il suo impiego.
PT90197A (pt) Processo para a preparacao de uma composicao anti-inflamatoria hidratante para a pele
PT90198A (pt) Processo para a preparacao de uma composicao anti-inflamatoria hidratante para a pele
DE3070545D1 (en) Bonding compositions to the hard tissue of human body
AU2003209285A1 (en) Deazapurine nucleoside analogs and their use as therapeutic agents
MX160316A (es) Procedimiento para preparar una composicion terapeutica de accion prolongada a base de hidroxipropilmetilcelulosa
CY1112753T1 (el) Θεραπευτικη αγωγη καρκινων του ανθρωπινου σωματος με τη χρηση toy ετ743
IT1184922B (it) Apparecchio per l applicazione controllata sul tessuto umano di sostanze riducenti per realizzare microabrasioni
ES535711A0 (es) Procedimiento para preparar una composicion para el tratamiento topico de acne
FI990171A0 (fi) Uusia yhdisteitä ja koostumuksia tryptaasiaktiivisuuden liittyvien tautien hoitamiseksi
BR9711296A (pt) Composto processo terap-utico para inibir o crescimento de c-lulas de c ncer e composi-Æo farmac-utica
CO5160321A1 (es) Novedosas composiciones de tipranavir y ritonavir
AU3683484A (en) The use of menthol to enhance transdermal drug delivery
FI883352A7 (fi) Kaksisäikeisen RNA:n käyttö tulehdusten hoitoon tarkoitetun lääkeaineen valmistamiseksi
IT1221826B (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
IS2257B (is) Samsetning með aselínsýru
ES287730Y (es) Un conjunto de punta aplicadora para usar en un instrumento similar a una pluma
WO2000041670A3 (fr) Formulations pharmaceutiques et procedes associes permettant une continuite de penetration
ES296537Y (es) Asa articulada para sillas de ruedas y otros dispositivos para incrementar la movilidad de impedidos fisicos.
FI955429L (fi) 1-aryylisykloalkyylisulfideja, sulfoksideja ja sulfoneja depression, tuskatilojen ja Parkinsonin taudin hoitamiseksi
DK599986D0 (da) Terapeutisk middel i form af et hudplaster

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase